Disputed rpoB mutations can frequently cause important rifampicin resistance among new tuberculosis patients.

Abstract

SETTING Greater Mymensingh area, Bangladesh. OBJECTIVES To document among new tuberculosis (TB) patients the proportions and treatment outcomes of silent, non-disputed and disputed (generally missed by rapid drug susceptibility testing [DST]) rpoB mutations, and their detection by commercial molecular assays. DESIGN Retrospective analysis of rpoB… (More)
DOI: 10.5588/ijtld.14.0651

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics